Selective COX-2 inhibitor regulates the MAP kinase signaling pathway in human osteoarthritic chondrocytes after induction of nitric oxide. [electronic resource]
- International journal of molecular medicine Feb 2005
- 213-9 p. digital
Publication Type: Journal Article
1107-3756
Annexin A5--pharmacology Apoptosis Blotting, Western Cartilage--metabolism Celecoxib Cell Separation Chondrocytes--drug effects Culture Media, Conditioned--pharmacology Cyclooxygenase 2 Cyclooxygenase 2 Inhibitors Cyclooxygenase Inhibitors--pharmacology Dinoprostone--metabolism Flow Cytometry Glycosaminoglycans--metabolism Green Fluorescent Proteins--metabolism Humans MAP Kinase Signaling System Membrane Potentials Membrane Proteins Microscopy, Fluorescence Mitochondria--metabolism Mitogen-Activated Protein Kinase 1--metabolism Mitogen-Activated Protein Kinase 3--metabolism Nitric Oxide--metabolism Osteoarthritis--drug therapy Prostaglandin-Endoperoxide Synthases--metabolism Pyrazoles--pharmacology Sulfonamides--pharmacology Time Factors p38 Mitogen-Activated Protein Kinases--metabolism